Effect of Benadryl Sedation During ERCP or EUS
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00240123 |
Recruitment Status :
Withdrawn
First Posted : October 17, 2005
Last Update Posted : September 18, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Gallbladder Disease Gallstones Pancreatitis Abdominal Pain Jaundice | Drug: Benadryl versus Placebo | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Diagnostic |
Official Title: | Effect of Diphenhydramine Sedation During Endoscopic Retrograde Cholangio-pancreatography (ERCP) or Endoscopic Ultrasound (EUS) |
Study Start Date : | July 2005 |
Study Completion Date : | July 2007 |

- Recovery score
- Quality of sedation

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients between 18 and 65 years of age who present for outpatient ERCP or EUS at Strong Memorial Hospital Endoscopy Center will be included
Exclusion Criteria:
- Allergy to diphenhydramine, narrow angle glaucoma, or inability to consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00240123
Principal Investigator: | Benedict Maliakkal, MD | University of Rochester Medical Center, Digestive and Liver Disease Unit |
ClinicalTrials.gov Identifier: | NCT00240123 |
Other Study ID Numbers: |
10454 |
First Posted: | October 17, 2005 Key Record Dates |
Last Update Posted: | September 18, 2015 |
Last Verified: | September 2015 |
ERCP EUS |
Pancreatitis Gallstones Gallbladder Diseases Abdominal Pain Jaundice Pancreatic Diseases Digestive System Diseases Pain Neurologic Manifestations Signs and Symptoms, Digestive Hyperbilirubinemia Pathologic Processes Skin Manifestations Cholelithiasis Biliary Tract Diseases |
Cholecystolithiasis Calculi Pathological Conditions, Anatomical Diphenhydramine Sleep Aids, Pharmaceutical Hypnotics and Sedatives Central Nervous System Depressants Physiological Effects of Drugs Anesthetics, Local Anesthetics Sensory System Agents Peripheral Nervous System Agents Antiemetics Autonomic Agents Gastrointestinal Agents |